BioPorto A/S - Extraordinary General Meeting, New Board Member
16 November 2021 - 1:55AM
BioPorto A/S - Extraordinary General Meeting, New Board Member
November 15,
2021Announcement
no. 20
BioPorto A/S - Extraordinary General
Meeting, New Board
Member
Today, BioPorto A/S
held an Extraordinary General Meeting
where Peter Mørch Eriksen was elected as new member of the
Board of Directors.
The proposals from the Board of Directors under
item 2 and 3 were also adopted:
a)
A renewal of the
authorization to issue warrants in Article 17a in the Articles of
Association, however limited so that (i) the aggregate number of
warrants outstanding shall not exceed the equivalent of 10% of the
Company’s share capital from time to time and that (ii) the maximum
share capital increase pursuant to the authorization shall be DKK
20,000,000, and
b)
Authorisation to
the Chairman of the general meeting.
Immediately following
the Extraordinary General Meeting, Thomas Magnussen
resigned from the Board of Directors, and Christopher Lindop was
elected as its new Chairman and John Patrick McDonough as its Vice
Chairman.
For further information, please contact:
Christopher Lindop, BioPorto A/S, + 45 45 29 00 00Tim Eriksen,
Investor relations, BioPorto A/S, +45 61 68 77 79
Email: investor@bioporto.com
About BioPortoBioPorto is an in vitro
diagnostics company that provides tests and antibodies to
clinicians and researchers around the world. We use our antibody
and assay expertise to transform novel research tools into
clinically actionable biomarkers that can make a difference in
patients’ lives. BioPorto is headquartered in Hellerup, Denmark and
is listed on the NASDAQ Copenhagen stock exchange [CPH:BIOPOR].
- 2021 11 15 - Announcement no. 20
Bioporto A/s (LSE:0JJM)
Historical Stock Chart
From Apr 2024 to May 2024
Bioporto A/s (LSE:0JJM)
Historical Stock Chart
From May 2023 to May 2024